Clearance of Longstanding Treatment-resistant Warts During COVID-19 in a Transplant Recipient
Overview
Infectious Diseases
Authors
Affiliations
Human papillomavirus (HPV), a DNA virus, infects basal keratinocytes and causes common warts and as well as malignancies of skin and mucous membranes. Although many treatment options are available, persistent HPV infections are common among transplant recipients. Herein, we present a patient with a 15-year history of treatment-resistant warts that regressed during COVID-19 (Coronavirus disease 2019) treatment.
Wu Q, Gao F, Zhang T, Zhang S, Bai Y, Zhu B Aging Med (Milton). 2024; 7(1):131-135.
PMID: 38571671 PMC: 10985768. DOI: 10.1002/agm2.12281.
Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV.
Bressler M, Delgado A, Charlie N JAAD Case Rep. 2022; 31:118-120.
PMID: 36406337 PMC: 9652155. DOI: 10.1016/j.jdcr.2022.11.007.
Clearance of recalcitrant verruca plana following COVID-19 vaccination.
Mohta A JAAD Int. 2022; 8:1-2.
PMID: 35308145 PMC: 8923995. DOI: 10.1016/j.jdin.2022.02.007.
Regression of common viral warts after ChAdOx1-S COVID-19 vaccine.
Plaszczynska A, Slawinska M, Sobjanek M J Eur Acad Dermatol Venereol. 2021; 36(3):e162-e164.
PMID: 34699635 PMC: 8657016. DOI: 10.1111/jdv.17771.
Insights into the management of anorectal disease in the coronavirus 2019 disease era.
Amjad W, Haider R, Malik A, Qureshi W Therap Adv Gastroenterol. 2021; 14:17562848211028117.
PMID: 34290826 PMC: 8274100. DOI: 10.1177/17562848211028117.